+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Immunoregulation in liver transplant recipients: possible evidence of tolerance by DTH assay

Immunoregulation in liver transplant recipients: possible evidence of tolerance by DTH assay


Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 035090034

Download citation: RISBibTeXText

PMID: 11267335

DOI: 10.1016/s0041-1345(00)02517-3

Related references

Monitoring the patient off immunosuppression. Conceptual framework for a proposed tolerance assay study in liver transplant recipients. Transplantation 72(8 Suppl): S13, 2001

In vitro correlates of transplant tolerance A preliminary study in liver transplant recipients. Human Immunology 62(Suppl. 1): S120, 2001

Recurrence of hepatitis B viral disease in liver transplant recipients Impact of pre-transplant HBV DNA screening by liquid phase hybridization assay. Hepatology 18(4 Part 2): 338A, 1993

Monitoring of human cytomegalovirus infection in bone marrow and liver transplant recipients by antigenaemia assay and enzyme-linked immunosorbent assay. Journal of International Medical Research 37(1): 31-36, 2009

Spontaneous and induced tolerance for liver transplant recipients. Current Opinion in Organ Transplantation 21(1): 53-58, 2016

Diagnostic yield of the cytomegalovirus (CMV) antigenemia assay and clinical features in solid organ transplant recipients and hematopoietic stem cell transplant recipients with CMV pneumonia. Transplant Infectious Disease 14(2): 192-197, 2012

Analysis of clinical variables associated with tolerance in pediatric liver transplant recipients. Pediatric Transplantation 14(8): 976-979, 2010

Liver histology in renal allograft recipients with chronic hepatitis C and without pre-transplant evidence of liver disease. Hepatology 30(4 Part 2): 456A, 1999

Tolerance and latent cellular rejection in long-term liver transplant recipients. Hepatology 28(2): 443-449, 1998

Evaluation of the new EMIT tacrolimus assay in kidney and liver transplant recipients. Transplantation Proceedings 36(1): 86-88, 2004

Comparison of pharmacokinetics of mycophenolic acid and its metabolites between living donor liver transplant recipients and deceased donor liver transplant recipients. Liver Transplantation 15(11): 1473-1480, 2009

Beyond the NIH Multicenter HIV Transplant Trial Experience: Outcomes of HIV+ Liver Transplant Recipients Compared to HCV+ or HIV+/HCV+ Coinfected Recipients in the United States. Clinical Infectious Diseases 61(7): 1054-1062, 2015

Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance. Liver Transplantation 19(9): 937-944, 2013

Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. Journal of Clinical Investigation 118(8): 2845-2857, 2008

Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients. Journal of Pharmaceutical and Biomedical Analysis 53(4): 997-1002, 2010